BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Medtech Med’s Industry

Bridge Biotherapeutics Partners with Emory University to Advance Lung Cancer Treatment

Bridge Biotherapeutics (KQ288330), a South Korean clinical-stage biotech company developing novel drugs for cancer, fibrosis, and inflammation, announ...

April 01, 2024 | News

Baird Medical Devices, Inc. Introduces Next-Generation Ceramic Thyroid Ablation Needle

Baird Medical Devices, Inc. ("Baird Medical" or the "Company"), a leading microwave ablation ("MWA") medical device developer and provider in China&nb...

April 01, 2024 | News

Resonance Health Joins Forces with Micron, Inc. for Strategic Entry into Japan's Healthcare Sector

Resonance Health Ltd, listed on the Australian Securities Exchange (ASX) under the ticker RHT, has officially announced its strategic move into the Japanes...

March 28, 2024 | News

GE HealthCare Launches AI-Driven Prostate Volume Assist to Transform Urological Imaging

New AI software feature will be available for use on the bkActiv, bk3000/5000 and bkSpecto active imaging systems Addition of AI solution advances...

March 28, 2024 | News

Scivita Medical Expands Collaboration with Boston Scientific

The introduction of iterative endoscopic technology has brought about a positive transformation in the field of endoscopy, making it an interventional tool...

March 26, 2024 | News

Bayer AG Partners with Thermo Fisher for Breakthrough in Cancer Treatment Diagnostics

Development of next-generation sequencing companion diagnostics (CDx) Goal is to help increase patient access to Bayer’s precision cancer therapie...

March 20, 2024 | News

A New Dawn in Heart Care: Singapore Leads with Innovative CVD Prevention Plan

In an interaction with BioPharma APAC, Dr. Low Lip Ping, Chairman Emeritus of the Singapore Heart Foundation, sheds light on the critical f...

March 20, 2024 | Interaction

Asieris Announces Breakthrough Non-Surgical Treatment for Cervical High-Grade Squamous Intraepithelial Lesion

Asieris Pharmaceuticals (Stock Code: 688176.SH), a trailblazer in the global biopharmaceutical industry with a focus on genitourinary tumors and related di...

March 19, 2024 | News

South Korean Lunit Forges Ahead in Europe with AI-Enhanced Cancer Detection

Lunit, a trailblazer in AI-driven diagnostics and cancer treatment, announced significant strides in its European market presence through new...

March 19, 2024 | News

Chipscreen Biosciences Announces Successful Phase II Trial of Chiglitazar for NASH Treatment

The CGZ203 study, a randomized, double-blind, placebo-controlled trial conducted across 24 national clinical sites, aimed to assess the saf...

March 19, 2024 | News

EDAN and GH Labs Collaborate to Develop AI-Enabled Ultrasound Devices

Under the agreement signed on March 13, 2024, in Bellevue, Washington, EDAN and GH Labs will combine their expertise to create innovative ul...

March 18, 2024 | News

Revvity Launches Revolutionary Newborn Sequencing Workflow to Advance Rare Disease Diagnosis

Revvity, Inc., a pioneering force in genomic sequencing technology, has announced the launch of a groundbreaking "sample-to-answer" workflow tailored speci...

March 18, 2024 | News

BeiGene's TEVIMBRA Wins FDA Nod for Advanced Esophageal Cancer Post-Chemotherapy

BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the U.S. Food and Drug Administration (FDA) has app...

March 15, 2024 | News

X-Therma Raises $22.4 Million in Series B Funding to Revolutionize Regenerative Medicine and Extend Organ Preservation

X-Therma Inc., an innovator in biotechnology focusing on regenerative medicine and organ preservation, announces the successful completion ...

March 14, 2024 | News

Stay Connected